Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease by unknown
ORGAN-SPECIFIC AUTOIMMUNE  DISEASES INDUCED IN MICE 
BY ELIMINATION  OF T  CELL SUBSET 
I. Evidence for the Active Participation of T  Cells in Natural Self- 
tolerance; Deficit of a  T  Cell Subset as a  Possible Cause of Autoimmune 
Disease 
BY SHIMON SAKAGUCHI,  KANZO FUKUMA,  KAGEMASA KURIBAYASHI, 
ANO THORU MASUDA 
From the Institute for Immunology, and the Department of Internal Medicine, Faculty of 
Medicine, Kyoto University, Kyoto 606, Japan 
A  number of clinical and experimental findings suggest the involvement of 
suppressor T cells in self-tolerance and autoimmune disease (1-3). It is, however, 
a  matter of conjecture whether a  defect in suppressor T  cells plays a  primary 
role in  the pathogenesis of autoimmune disease, or only an incidental one. A 
definitive experiment would be one in which autoimmune disease is induced by 
the removal of suppressor  T  cells from the immune system of an  otherwise 
normal animal, and, further, self-tolerance can be reestablished, and autoimmune 
disease prevented, by reconstituting such an animal with suppressor T  cells. 
Organ-specific autoimmune disease can be induced in rodents by treatments 
that deplete a subpopulation of T  cells: Neonatal thymectomy of some strains of 
mice caused autoimmune disease in several endocrine organs (4).  Autoimmune 
thyroiditis developed  in  adult  rats  that  underwent  thymectomy followed by 
repeated sublethal irradiation (5).  Since the appearance of autoimmune disease 
was clearly prevented by the reconstitution of these animals with T  cells from 
syngeneic normal animals (6, 7), it has been postulated that autoimmune disease 
may result  from depletion  of a  specific T  cell  subpopulation  responsible  for 
checking and controlling self-reactive (i.e., autoimmune) lymphocyte clones. 
In analyzing the pathogenesis of murine, organ-specific autoimmune diseases 
after neonatal thymectomy, we have shown (6) that neonatal thymectomy caused 
diminution of T  cells, especially those of the Lyt-1 ÷, 2,3- (Lyt-1) T  cell subset, 
from  peripheral  lymphoid organs.  Furthermore,  reconstitution  of thymecto- 
mized mice with Lyt-1  cells prepared from normal syngeneic mice completely 
inhibited disease development. These findings prompted us to examine whether 
direct elimination of the  Lyt-1  population  from a  normal adult mouse could 
cause autoimmune disease, particularly of the organ-specific type. In this report, 
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we describe our attempt to reconstitute congenitally T  cell-deficient nude (nu/ 
nu) mice with selected Lyt spleen cell subset(s) from euthymic (nu/+) heterozy- 
gotes, and studied the immunopathology of the recipient nude mice to determine 
whether autoimmune disease might occur. 
Materials and Methods 
Mice.  BALB/c nude and their heterozygous (nu/+) littermates, originally a gift from 
Dr.  B.  Kindred, Basel  Institute for Immunology, Switzerland, were obtained from the 
Institute of Medical Science, University of Tokyo, Japan. They were bred under specific 
pathogen-free conditions in the Facility of Experimental Animals at Kyoto University by 
mating nu/nu males with nu/+ females. The age and sex of the mice used are indicated 
in Results.  The phenotype of T  cell surface antigens of BALB/c nu/+ mice is Thy-l.2, 
Lyt-l.2, 2.2, 3.2. 
Antisera.  The antisera against Thy-l.2 and Lyt antigens were prepared by standard 
alloimmunization using congenic mice (8).  Their titers and specificities were described 
previously (9).  Monoclonal antibodies (mAb)  ~ anti-Lyt-l.2 ('r2a,k) [anti-Lyt-l.2(m)] (10) 
and anti-Lyt-2.2 (3,2a,k)  [anti-Lyt-2.2(m)] (11), both from ascites,  were gifts from Dr. 
F.-W. Shen, Memorial Sloan-Kettering Cancer Center, New York, and Dr. E. Nakayama, 
Center for Adult Diseases,  Osaka, Japan,  respectively. Their titers at 50% cytotoxicity 
were 1:10,000 and 1:25,000, respectively, by trypan blue dye exclusion test(12). 
Treatment of Cells With Antisera and Complement (C).  Bulk treatment of cells was carried 
out as previously described (9).  Briefly, 2 X  l0  T spleen cells in 0.2 ml of Medium  199 
(Gibco Laboratories, Grand Island, NY) with 2% fetal calf serum (FCS) (Gibco Labora- 
tories) were incubated at 4 °C with conventional anti-Thy-1.2, Lyt-1.2, Lyt-2.2, or normal 
mouse serum (NMS) at final dilution of 1:7, with occasional vigorous shaking. After 40 
rain, 0.75 ml of 1:6 diluted rabbit serum, selected for high C activity and low toxicity, 
was added. After an additional 30 min incubation at 37°C in a waterbath, the cells were 
washed twice with cold medium containing 5% FCS and suspended in 0.5 ml of serum- 
free medium,  to  be injected into  the  mice.  By this  protocol, the  percentage of cells 
eliminated in a typical experiment by each antiserum and C was as follows: NMS, 12.3%, 
anti-Thy-l.2, 36.1%; anti-Lyt-l.2, 35.7%; and anti-Lyt-2.2, 26.7%. mAb were used at a 
dilution of l:10 of the original ascites. 
Histological and Serological Examination.  Organs or tissues (thyroid, parathyroid, lung, 
salivary gland, liver, stomach, small and large intestine, pancreas, kidneys, adrenal glands, 
spleen, lymph nodes, ovaries, epididymides, and testes) from individual mice were fixed 
in  10%  formalin, embedded in  paraffin, sectioned, and  stained  with  hematoxylin and 
eosin (HE) for histological examination. For immunofluorescence (IF) to detect autoanti- 
bodies, various normal tissues were fixed in neutral, buffered formol saline, and embedded 
in alcohol-miscible wax of low melting point (37°C) (polyester wax; BDH Chemicals Ltd., 
Poole, Dorset, United Kingdom) (13).  Histological quality of tissue sections prepared by 
this method was better than that of frozen sections, and antigenicity tested by IF was 
comparable. After dewaxing with graded concentrations of ethyl alcohol and phosphate- 
buffered saline (PBS),  the tissue sections were incubated for 30  min at 37°C with the 
mouse serum to be tested. After washing with PBS,  they were treated with fluorescein 
isothiocyanate (FITC)-Iabeled goat anti-mouse IgG (Miles Yeda, Rehovot, Israel) diluted 
1:20, incubated 30 min further at 37 °C, washed, and examined with a Zeiss photomicro- 
scope. For the detection of thyroglobulin autoantibody, the hemagglutination test using 
human type O red blood cells coated with mouse thyroglobulin was used (14). Circulating 
immune complexes were measured by conglutinin-binding assay with sera of old MRL/ 
MpJ-lpr/lpr mice as positive control (15). 
i Abbreviations  used in this paper:  FCS,  fetal calf serum; IF, immunofluorescence; HE, hematoxylin 
and eosin; mAb, monoclonal antibody; NMS, normal mouse serum; PBS, phosphate-buffered saline. 74  REMOVAL  OF  T  CELL  SUBSET  CAUSES  AUTOIMMUNITY  IN  MICE 
Results 
By the C-dependent cytotoxicity test, the composition of Lyt subsets among 
Thy-1 +, nylon wool-nonadherent spleen cells from 3-mo-old BALB/c nu/+ mice 
was as follows: Lyt-1 ÷, 2,3,-(Lyt- 1) cells, 40%; Lyt-1 +, 2,3 + (Lyt-1,2,3) cells, 50%; 
Lyt-l-, 2,3 + (Lyt-2,3) cells, negligible, if present; and Lyt-l-, 2,3-(Lyt-) cells, 5- 
10% (for more about Lyt- cells, see Discussion). 
Induction of Oophoritis, Gastritis, and Thyroiditis in Female nu/nu Mice.  Spleen 
cells (4 ×  107) from 10-12-wk-oid female nu/+ mice were treated with various 
antisera  plus C, then transferred  intravenously,  into 6-8-wk-old female nu/nu 
mice. Recipients were killed 3 mo later, and examined histologically and serolog- 
ically for the development of autoimmune disease (Table I). Neither NMS plus 
C, nor anti-Thy-1  plus C-treated cells caused any pathological alteration in the 
nu/nu mice. However, when the spleen cells treated with anti-Lyt-1 plus C were 
transferred (Table I, group C), ovaries, stomach, and/or thyroid gland of some 
of the  recipients  were  destroyed,  shown  also  in  Figs.  1  and  2.  Some  mice 
developed disease in only one organ, others in more than one. Other organs and 
TABLE  I 
Induction of Autoimmune Diseases in Female nu/nu Mice by the Transfer of Spleen Lyt Subsets 
From Female nu/+ Mice* 
Experi-  Number of 
mental  Treatment of cells*  cells treated 
group  (x 107) 
Incidence of autoimmune diseases* 
Oophoritis  Gastritis  Thyroiditis 
A  NMS  4  0/12  e  0/12  0/12 
B  Anti-Thy-1.2  4  0/10  0/10  0/10 
C  Anti-Lyt-l.2  4  6/12 (50.0)  3/12 (25.0)  1/12 
D  Anti-Lyt-2.2  4  0/10  0/10  0/10 
E  C +  D I  2 (each)  0/10  0/10  0/10 
F  Anti-Lyt-l.2 and anti-Lyt-  4  8/15 (53.3)  4/15 (26.7)  3/15 
2.2 
G  Anti-Lyt-l.2(m) and anti-  4  6/12 (50.0)  2/12 (16.7)  1/12 
Lyt-2.2(m)  I 
H  Anti-Lyt-1.2, anti-Lyt-2.2,  4  0/10  0/10  0/10 
and anti-Thy-1.2 
I  D +  F**  2 (each)  0/10  0/10  0/10 
J  D +  F**  I(D), 3(F)  0/10  0/10  0/10 
(8.3) 
(20.0) 
(8.3) 
* Spleen cells from 10-12-wk-old female nu/+ mice were treated with antiserum plus C, as indicated, 
and transferred intravenously to 6-8-wk-old female nu/nu mice. Recipient nu/nu mice were killed 
3 mo after transfer. 
* Incidence of disease  was  assessed  by  histological  examination  of each  organ.  Autoantibodies 
specific for corresponding organs could be detected histologically in the mice developing disease 
(see also Figs.  1-4). 
0 Number of mice with each disease per total number of mice in a group. Percent incidence, when 
disease developed, is indicated in parentheses. 
m  Mixture of two cell populations: spleen cells (2 ×  10 7) treated with anti-Lyt-1.2 plus C and others 
(2 ×  10 7) treated with anti-Lyt-2.2 plus C. 
i Spleen cells (4 ×  10 7) were treated like group F, with anti-Lyt-l.2 mAb and anti-Lyt-2.2 mAb, 
plus C. 
** Spleen cells (2 ×  10 7) were treated like group D (anti-Lyt-2.2 plus C), and 2 x  10 7 spleen cells like 
group F (anti-Lyt-1.2 and anti-Lyt-2.2 plus C), then combined before transfer. 
** Spleen cells (10 7) were treated  like group D (anti-Lyt-2.2 plus C) and  3  ×  10 7 spleen cells like 
group F (anti-Lyt-1.2 and anti-Lyt-2.2 plus C), then combined before transfer. SAKAGUCHI  ET  AL.  75 
TABLE  II 
Induction of  Autoimmune Diseases in Male nu/nu Mice by the Transfer of  Spleen Lyt Subsets 
From Male nu/+ Mice 
Experimental  Treatment of  Incidence of autoimmune diseases* 
group  cells*  Orchitis  Gastritis  Thyroiditis 
A  NMS  0/10  e  0/10  0/10 
B  Anti-Lyt-l.2  5/12 (41.7)  3/12 (25.0)  0/12 
C  Anti-Lyt-2.2  0/10  0[  10  0/10 
D  Anti-Lyt-l.2 and  6/15 (40.0)  3/15 (20.0)  2/15 (t3,3) 
anti-Lyt-2.2 
* 4 x  107 spleen cells from 10-12-wk-old male nu/+ mice were treated with the antiserum indicated, 
plus C, and then transferred intravenously  to 6-8-wk-old male nu/nu mice. Recipient nu/nu mice 
were killed 3 mo later for histological and serological examination. 
*,a See footnotes to Table I. 
FIGURE  1.  Macroscopic  view  of organs  from  nu/nu  mice  suffering autoimmune disease 
(Table l F and Table I 1D). Oophoritis, gastritis, thyroiditis, and epididymitis-orchitis (right  side ~ 
of each photograph); intact control organs from untreated nu/nu mice (left). (A) Ovary (x 2), 
(B) stomach (x  1.5), (C) thyroid (x 4), (D), testis (X  1). 
tissues examined (see Materials and Methods) were intact, macroscopically and 
microscopically. We found circulating autoantibodies specific for organ compo- 
nents in the sera of diseased nu/nu mice by indirect IF (see Fig. 3).  In contrast, 
no disease or autoantibodies appeared after transfer of nu/+ spleen cells that 
were treated with anti-Lyt-2 plus C  (Table  I,  group D).  The reconstitution of 
nu/nu mice with a mixture of cells treated with anti-Lyt-1 plus C and anti-Lyt-2 
plus C, so that Lyt-l,2,3 cells were absent, also failed to cause any disease in the 
recipients (Table I, group E). 76  REMOVAL  OF  T  CELL  SUBSET  CAUSES  AUTOIMMUNITY  IN  MICE 
FIGURE 2.  Histology of organs developing autoimmune diseases (B, D, F, H, J) (Table IF 
and Table liD); and of intact control organs from  untreated nu/nu  mice (A, C, E,  G, I). 
Ripening or growing follicles, with oocytes and corpora lutea, seen in normal ovary (A) (× 80) 
are destroyed in oophoritis (B) (x 80) with diffuse infiltration of mononuclear cells. Gastric 
mucosa with normal architecture (C)  (x  120)  is damaged  in gastritis (D) (x  120).  Loss  of 
parietal cells  and compensatory hyperplasia of mucous cells  result in thickening of gastric 
mucosa.  Inflammatory cells,  mainly mononuclear cells,  infiltrate into the  submucosa and 
epithelium. Acinar follicles  in normal thyroid gland (E) (x 200) are obliterated and replaced 
by the  interstitial cell  infiltration in  thyroiditis (F)  (x  200).  Ducts  in  normal epididymis 
containing  mature sperm (G) (X 200) and'seminiferous  tubules with spermatogenesis in normal 
testis (1) (x 200) are damaged and replaced by massive infiltration of mononuclear cells and 
some polymorphonuclear cells in epididymitis (H) (x 200) and orchitis (J) (x 200). No sperm 
were observed, and spermatogenesis is abolished in epididymitis-orchitis. (HE stain). SAKAGUCHI ET AL.  77 
After the removal of Lyt-1 ÷ cells by anti-Lyt-1 plus C treatment, Lyt-2,3 and 
Lyt- cells remain. To identify the cell population responsible for the induction 
of disease, we tried to eliminate all Lyt  + cells by treating nu/+ spleen cells with 
a  mixture  of anti-Lyt-1  and  anti-Lyt-2,  plus  C  (Table  IF).  This  population, 
containing Lyt- cells but not Lyt-2,3 cells, induced disease with about the same 
incidence as anti-Lyt-1  plus C-treated cells. Similar treatment with anti-Lyt-1 
and anti-Lyt-2 mAb, plus C, induced disease with almost the same incidence as 
with conventional anti-Lyt sera (Table I G). Because treatment with mixed sera 
of anti-Thy-1,  anti-Lyt-1,  and  anti-Lyt-2,  plus  C,  completely abrogated  the 78  REMOVAL  OF  T  CELL  SUBSET  CAUSES  AUTOIMMUNITY  IN  MICE 
disease-inducing capacity  of nu/+ spleen  cells  (Table  IH),  these  results,  alto- 
gether,  indicate  that Thy-1 +,  Lyt- cells were responsible for the induction of 
autoimmune disease. 
As noted above, transferred cell populations that contained Lyt-1 cells did not 
cause disease, even if they also included Lyt- cells (Table I, A, D, and E). This 
finding was further substantiated by the transfer of Lyt-1 cells mixed with Lyt- 
cells in different ratios:  when anti-Lyt-2 plus C-treated  cells, which were pre- 
sumed to contain Lyt-1  and Lyt- cells (prepared from 2  x  10 7 [Table I, group 
I] or  1 x  10 7 [Table  I,  group J]  nu/+ spleen cells), were combined with Lyt- 
cells (prepared from 2  x  10 7 or 3  ×  10 7 nu/+ spleen cells), and transferred to 
nu/nu  mice,  the  development  of all  three  autoimmune  diseases  was  clearly 
inhibited in both groups of recipients. These results suggest that the Lyt-1 cells 
can suppress the ability of Lyt- cells to induce autoimmune disease. 
Induction of Orchitis, Gastritis, and  Thyroiditis in Male nu/nu Mice.  When a 
spleen  cell  suspension (4  x  10 7 cells)  from  male nu/+  mice was  depleted  of 
specific Lyt subset(s) and transferred to male nu/nu mice, some recipients of the 
anti-Lyt-1 plus C-treated (Table liB) or anti-Lyt-1 and anti-Lyt-2 plus C-treated 
cells (Table liD) developed orchitis, gastritis, and/or thyroiditis.  NMS plus C- 
or anti-Lyt-2 plus C-treated cells did not induce disease. 
Histopathology of  Each Autoimmune Disease and Circulating  Autoantibodies Specific 
for  Corresponding Organ Components.  Figs.  1  and  2  show  macroscopic  and 
microscopic views, respectively, of affected organs  from the nu/nu mice with 
autoimmune diseases.  The ooporitic ovaries became involuted and the uterus 
atrophied,  probably  because  of a  deficiency of ovarian  hormones  (Fig.  1A). 
Destruction of gastric parietal cells, which secrete hydrochloric acid, and com- 
pensatory hyperplasia of mucous cells seem to be responsible for achlorhydria 
and  the  formation  of giant  rugae  in  the  cases  of gastritis  (Fig.  1 B).  Goiters 
developed in the thyroid glands of mice with thyroiditis (Fig.  1 C).  Epididymes 
and testes afflicted with epididymitis and/or orchitis became involuted (Fig. 1 D). 
Histologically (Fig.  2),  each  disease  was  characterized  by  damage and  loss of 
specific organ components: oocytes, gastric parietal cells, thyroid follicular cells 
and colloid, and sperm, accompanied by the massive infiltration of inflammatory 
cells, mainly mononuclear cells (for further description of histology, see legend 
to Fig. 2). 
Fig. 3 shows the presence of autoantibodies specific for corresponding organ 
components detected by indirect IF in the circulation of diseased nu/nu mice: 
Anti-zona pellucida antibody in oophoritis (some oophoritis-bearing mice also 
developed anti-ooplasm antibody), anti-parietal  cell antibody in gastritis,  anti- 
colloid antibody  in  thyroiditis (which included antithyroglobulin antibody,  as 
demonstrated by the thyroglobulin-hemagglutination test described in the legend 
of Fig. 4), and antisperm antibody in epididymitis-orchitis. 
Titers of circulating autoantibodies in individual mice receiving anti-Lyt-1 and 
anti-Lyt-2  plus  C-treated  nu/+  spleen  cells  (Table  IF,  and  Table  liD)  were 
determined by IF (Fig. 4). In accordance with the results in Tables I and II, mice 
that developed histologically identified disease also had autoantibodies against 
corresponding organ constituents. SAKAGUCHI  ET  AL.  79 
FIGURE 3.  Autoantibodies  specific for  corresponding  organs.  Normal  organs  from  nu/+ 
mice are stained by the sera from nu/nu mice bearing each disease. (A) Anti-zona pellucida 
autoantibody in oophoritis, x  400. Ovary from 20-d nu/+ mouse is stained. (B) Anti-parietal 
cell autoantibody  in  gastritis,  x  400.  (C) Anticolloid autoantibody  in thyroiditis,  x  200.  (D) 
Antisperm  autoantibody  in  orchitis,  x  400.  Staining of sperm  smear  is  inserted,  x  1600. 
Acrosomes of sperm are stained. 
Other Autoimmune Phenomena.  Under our conditions for maintaining  nu/nu 
mice, ~40-50%  of the untreated nu/nu mice ~3 mo old developed antinuclear 
antibodies, assessed by IF. This has also been reported by others (16). However, 
no significant increase in incidence or titer of antinuclear antibodies was observed 
in mice with organ-specific autoimmune disease. In addition, in none of the mice 
examined was Coombs' antibody present;  circulating  immune complex was not 
detected in the sera of the treated nu/nu mice, and glomerulonephritis or angitis 
due to immune complex desposition was not observed histologically. 
Adoptive Transfer of  Autoimmune Disease Into Other nu/nu Mice.  Spleen cells (4 
x  107 cells) from the disease-bearing nu/nu mice (Table I, C and F, and Table 
II, B and D) were introduced  intravenously into other nu/nu mice of the same 
sex as the donors.  Fig.  5 shows that the histological lesion in each disease could 
be specifically transferred within 60 d of the initial cell inoculation, with concom- 
itant development of circulating  specific autoantibodies.  Since the treatment  of 
donor spleen cells with anti-Thy-1  and C abrogated their capacity to transfer the 
disease (Table  III),  these  results,  taken  together,  suggest that  effector T  cells 
specific for each target  organ  are required  for the successful transfer  of these 
organ-specific autoimmune diseases. 80  REMOVAL  OF  T  CELL  SUBSET  CAUSES  AUTOIMMUNITY  IN  MICE 
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FIGURE 4.  Titer of autoantibodies in the sera from female (A) and male (B) nu/nu mice given 
nu/+ spleen cells treated with anti-Lyt-I and anti-Lyt-2 plus C (Table IF and Table lID). (O) 
Histologically intact ovaries. (0) Almost all follicles  and oocytes were destroyed. (A) Intact 
gastric mucosa. (&) Gastritis developed macroscopically and microscopically (see also Figs.  1B 
and 2D). (I-I) Histologically intact thyroid gland. (11) Thyroiditis developed with goiter (see 
Figs. 1C and 2F). (O) Intact epididymis and testis. (9)) Both epididymitis  and orchids occurred. 
In  the  sera  of  thyroiditis-bearing mice,  antithyroglobulin antibody  was  detected  by  the 
hemagglutination test: hemagglutinating titers were, for mice in A, × 1280, x640, and ×320; 
and in B, ×640 and x320, respectively. 
Discussion 
By dissecting splenic T  cells taken from nu/+ mice into subpopulations, based 
on their expression of Lyt antigens, and then transferring such Lyt subsets to 
nu/nu mice,  we  were  able  to  induce autoimmune diseases  in  several  organs, 
including  ovary,  stomach,  thyroid,  and  testis.  These  organs  were  damaged 
histologically  by  massive  infiltration  of inflammatory  cells,  with  concomitant 
development of autoantibodies specific for particular components in each organ: 
oocytes,  parietal  cells,  thyroid  colloid  (including thyrogiobUlins),  and  sperm. 
Thy-1 +, Lyt- cells were shown to be responsible for inducing disease, and Lyt-1 
cells, when mixed with the Lyt- cells, were shown to have suppressive activity on 
the development of disease. 
There are some controversies concerning the expression of Lyt antigens on SAKAGUCHI  ET  AL.  81 
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FIGURE 5.  Adoptive transfer of autoimmune diseases (oophoritis, gastritis, thyroiditis, and 
orchitis) into other nu/nu mice. Spleen cells (4 X l0 T) from  nu/nu mice developing each 
autoimmune disease (Table 1, C and F, and Table II, B and D) were inoculated intravenously 
into 6-8-wk-old nu/nu mice. The recipients were killed 30 or 60 d after transfer for histological 
and serological examination. (O, O, A, &, D, B, 0,9)) See legend to Fig. 4. (A) Gastritis not 
remarkable macroscopically but histologically detectable. (FI) Thyroiditis developed histologi- 
cally, but goiter was not formed yet. (()) Epididymitis developed, but testis was histologically 
intact. 
lymphocytes.  Whether  Lyt-1  antigens  are expressed on all T  cells, and even on 
B cells, when examined  by such exquisite assays as cytofluorometry (17,  18) is, 
as yet, uncertain.  The definition of Lyt- cells in this report is an operational one, 
based on a  C-dependent  cytotoxicity assay. We do not mean to assert that  Lyt- 
cells are necessarily devoid of all Lyt antigens;  their expression on Lyt- cells may 
be too low for lysis with antibody plus C. It may be more appropriate,  therefore, 
to designate Thy-1 ÷, Lyt-l-, 2,3- as Thy-l~,  Lyt-1J,, 2,3J,, as suggested by Shiku 
et al (19). Thy-1 +, Lyt- cells detected by cytotoxicity or membrane IF assay have, 
thus far, been reported  in normal  spleen and in lymph nodes (20), from in vitro 
mixed lymphocyte reactions (21), in mitogen-stimulated  T  blast populations (22), 
from a cell line maintained  by T  cell growth factors (23), in lymphoadenopathy 
of lupus-prone  MRL  mice  (24),  and  in  the  infiltrating  cells  in  experimentally 
induced  allergic  thyroiditis  (25).  Lyt-  cells  are  also  rich  in  peripheral  blood 
lymphocytes of normal  mice (Nakayama and Sakaguchi,  unpublished data).  Lyt- 
cells, prepared  by C-dependent  cytotoxic depletion,  seem to be a distinct T  cell 
subset as  unique  as other  Lyt subsets.  Since  the  adoptive  transfer  experiment 
suggested the existence of specific effector T  cells for each autoimmune  disease 
(Fig. 5 and Table III), Lyt- cells could be considered precursors of such effector 
T  cells. In the cases ofautoimmune oophoritis, induced by neonatal thymectomy, 82  REMOVAL  OF  T  CELL  SUBSET  CAUSES  AUTOIMMUNITY  IN  MICE 
TABLE  III 
Requirement of T Celts  for Adoptive Transfer of  Autoimmune Diseases 
Autoimmune disease(s)  Treatment of 
cells trans- 
Exp.  in donor nu/nu mouse*  ferred* 
Autoimmune disease(s) induced in recipient 
nu/l~u  mouse  {} 
Oophoritis  Gastritis  Th.yroid-  Orchitis 
Itls 
Oophoritis  NMS  +  (640)  m 
Anti-Thy-1.2  - 
m 
B 
Oophoritis, gastritis  NMS  +  (320)  +  (320) 
Anti-Thy-1.2  - 
m 
R 
Thyroiditis  NMS 
Anti-Thy-1.2 
Oophoritis,  thyroiditis  NMS  +  (160) 
Anti-Thy-l.2  - 
+  (640) 
+  (640) 
5  Orchitis  NMS  -  -  +  (320) 
Anti-Thy-1.2  -  -  - 
* Those nu/nu mice with autoimmune diseases (Table I F  and Table II D) were used as the spleen 
cell donors. 
* Spleen cells (4 ×  107) from disease-bearing nu/nu mice were treated.  ~ 15% of the donor spleen 
cells were Thy-1 + by cytotoxicity test. 
0 Donor nu/nu mice and recipient nu/nu mice were of the same sex.  Recipient nu/nu mice aged 
6-8 wk were inoculated with spleen cells intravenously, and killed 60 d  later. 
I Autoimmune disease developed histologically (+), as shown in Figs.  1 and 2. Organ  histologically 
intact (-).  Titer of autoantibodies specific for the corresponding organ components was assessed 
by IF, as shown in Fig. 5. Values are given in parentheses for titers _>10. 
and experimental allergic thyroiditis, the autoimmune diseases can be adoptively 
transferred to syngeneic mice or nude mice by Lyt-1 cells alone (9), or by a Lyt- 
1 T  cell line maintained in vitro by exogenous growth factors (26). It is conceiv- 
able, therefore, that the Lyt- (Lyt-l~, 2,3~) population might give rise to Lyt-1 
effector T  cells. Since nude mice are known to have a small number of Thy-1 + 
cells (27), it is also plausible that the transferred nu/+ Lyt- cells might interact 
with nu/nu Thy-1 ÷ cells and induce them to  differentiate into  effector cells. 
These possibilities are now under investigation. 
Lyt-1  cells  have  been  shown  to  have  suppressive  activity  on  cellular  and 
humoral immunity in an antigen-specific or -nonspecific manner (28-30). Recent 
investigations  (31,  32)  of T  cell  regulatory  mechanisms  in  various  immune 
responses have revealed suppressor circuits or cascades. These circuits involve 
interactions  among  Lyt  subsets,  via  suppressive  factors  and/or  antiidiotypic 
antibodies. The role of Lyt-1 cells as inducers (31) or first-order suppressors has 
received special emphasis (32). In our experiments, Lyt-1 cells were sufficient to 
suppress  the development of disease, apparently by acting directly upon  Lyt- 
cells.  Further investigation of Lyt-1  cells and their mode of action in actively 
regulating self-reactive clones is needed, especially to determine whether they 
are specific for each organ-antigen, and, if so, when and how they are sensitized 
to  self-antigens  to  acquire  regulatory  activity.  Other  Lyt  subsets  and  their SAKAGUCHI  ET  AL.  83 
interactions with Lyt-1 cells might also be involved if Lyt- cells can differentiate 
into other (Lyt  +) subsets. 
In nude mice or mice depleted of T  cells (by thymectomy, irradiation, and 
reconstitution with bone marrow cells), no organ-specific autoimmune disease 
develops spontaneously  under  control  conditions.  Nor  can  it  be  induced by 
exogenous immunization with self-antigen such as thyroglobulin and adjuvant 
(33). In the present experiment, nu/+ spleen cell suspensions freed of a particular 
T  cell subset (i.e., Lyt-1 + cells) could induce autoimmune disease in nude mice, 
but those depleted of all T  cells could not. Together with the necessity for T 
cells in adoptive transfer, these findings suggest that T  cells may be required, 
not only for the maintenance of self-tolerance, but also for inducing autoimmun- 
ity, leading to eventual destruction of self-tissues. Without constant help from 
the effector T  cells,  B  cells seem  to  be  incapable  of forming autoantibodies 
quantitatively or qualitatively sufficient to cause tissue damage, even if they may 
have the repertoire for self-constituents. This dependency has been demonstrated 
for human peripheral  B  cells binding thyroglobulin (34);  the development of 
such self-reactive T  cells, including helper T  cells for autoantibody formation 
and/or T  cells mediating cellular autoimmune reactions (9),  may, in  turn,  be 
checked and controlled by another T  cell subset(s), in a healthy condition. 
With  respect to  the  spectrum of organs  affected, and  immunopathological 
features of individual  diseases and  their  chronicity, the autoimmune diseases 
induced  in  the  nude  mice  are  similar  to  human  organ-specific autoimmune 
diseases: Hashimoto's thyroiditis, atrophic gastritis with pernicious anemia, pre- 
mature ovarian failure with antioocyte autoantibody (35),  and male infertility 
with  antisperm autoantibody.  In  the  human,  one organ-specific autoimmune 
disease is frequently associated with another (36). For organ-specific autoimmune 
disease to be complicated with a non-organ-specific one, such as systemic lupus 
erythematosus, however, is rare (37). It is noteworthy, therefore, that even when 
the nude mice developed autoimmune disease on more than one organ, they did 
not develop non-organ-specific autoimmunity or immune complex disease, as 
seen in the lupus-prone NZB or MRL strains of mice (38), or mice with chronic 
graft-vs.-host disease (39). Conversely, in these models of systemic autoimmunity, 
few organ-specific autoimmune diseases,  if any, have been reported (38,  39). 
This suggests that the pathogenic mechanisms of these two groups of autoim- 
munities may be different. 
Whether there might be some unifying element among the current theories 
of immunological tolerance to both self- and non-self-antigens is still in question, 
i.e., clonal deletion (40), T and/or B cell inactivation (41-43), or active regulation 
by suppressor T  cells (44). Accordingly, it is also a matter of debate whether the 
pathogenic mechanism of autoimmune disease can be explained by any single 
concept. Forbidden clones (40), T  cell bypass mechanisms (2, 43), or defects in 
suppressor T  cells (45)  need to be thoroughly considered. Our present study 
strongly suggests that organ-specific autoimmune diseases can be produced by a 
deficit or defect in a particular T  cell subset(s) that appears to have a suppressive 
effect on  self-reactive lymphocytes. Active cellular interactions among T  cell 
subsets, the suppressor subset being dominant in the healthy state, is presumably 
responsible for maintaining physiological self-tolerance to some self-constituents. 84  REMOVAL  OF  T  CELL SUBSET CAUSES AUTOIMMUN1TY IN  MICE 
Environmental agents, infectious or toxic, may exist which selectively affect the 
suppressor subset to cause organ-specific autoimmune diseases. 
Summary 
Organ-specific autoimmune diseases such as oophoritis, gastritis,  thyroiditis, 
and orchitis were induced in female or male nude (nu/nu) mice by the transfer 
ofnu/+ spleen cells from which particular Lyt T cell subset(s) had been removed: 
nu/+ spleen cells treated with anti-Lyt-1 plus complement (C) caused disease in 
recipient nude mice; anti-Lyt-2 plus C-treated spleen cells, in contrast, did not. 
The cells responsible for disease induction are believed to be Thy-1 +,  Lyt-l-, 
2,3-  (Thy-l~',  Lyt-l~,  2,3~),  since  spleen  cells  treated  with  mixed  antisera, 
including anti-Lyt-1 and anti-Lyt-2, plus C, could induce the disease with almost 
the same incidence as anti-Lyt-1 plus C-treated cells (oophoritis 50%,  gastritis 
25%,  thyroiditis 10-20%,  and orchitis 40%).  Cells treated with mixed antisera 
of anti-Thy-1, anti-Lyt-1, and anti-Lyt-2, plus C, could not induce autoimmune 
disease. 
Each induced autoimmune disease could be adoptively transferred to other 
nude mice via spleen cells, with resulting histological lesion of corresponding 
organs and development of specific circulating autoantibodies. Since anti-Thy-1 
plus C  treatment of donor spleen cells abrogated the capacity to transfer the 
disease, we conclude that T  cells are required as effector cells, and that these 
may develop from Lyt-l-, 2,3- cells. 
Lyt-1 +,  2,3-  cells were demonstrated to  have suppressive activity upon  the 
development of the diseases; induction of autoimmunity was completely inhibited 
by the cotransfer of Lyt-1 +, 2,3- cells with Lyt-l-, 2,3- cells. When anti-Lyt-2 
plus C-treated cells (i.e., Lyt-1 +,  2,3- and Lyt-l-, 2,3- cells) were mixed with 
anti-Lyt-1 and anti-Lyt-2 plus C-treated cells (i.e., Lyt-l-, 2,3- cells) in various 
ratios,  then transferred to  nude mice, the development of each autoimmune 
disease was clearly inhibited, even by small doses of Lyt-1 +, 2,3- cells. 
The autoimmune disease we were able to induce was quite similar to human 
organ-specific autoimmune disease in terms of the spectrum of organs involved, 
histopathological features, and the development of autoantibodies to correspond- 
ing organ components (oocytes, parietal cells, thyroid colloid, including thyro- 
globulin, and sperm). The results offer direct evidence for the active participation 
of T  cells in natural self-tolerance to certain self-constituents, and suggest that a 
deficit or defect in certain T  cell subset(s) is a  possible cause of organ-specific 
autoimmune disease in humans. 
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